Navigation Links
Advantages of Roche Applied Science amplification products

The Polymerase Chain Reaction invented by Kary Mullis in 1983 drastically changed the course of modern life science research by opening an enormous variety of new opportunities to study and understand the crucial role of nucleic acids in living organisms. Roche Applied Science recognized early-on the importance of this new technology and the necessity to have a thermostable enzyme available allowing the scientific community to exploit the Polymerase Chain Reaction. Since then, Roche Applied Science has strived to continuously perfect the Polymerase Chain Reaction. By exploiting their traditional experience in producing biochemicals and enzymes, RAS has developed and perfected a broad range of new associated technologies and more powerful enzyme preparations. Today, these highly optimized, innovative preparations enable scientists to obtain performance beyond the standard in specificity, sensitivity, accuracy and reproducibility. Roche Applied Science has a strict set of guidelines based upon its overall quality philosophy:
  • All amplification reagents have without any compromises the highest possible purity
  • All amplification reagents are rigorously function tested using the most stringent quality control criteria
  • All amplification reagents are produced using state-of-the-art facilities and technologies
  • All available in-house knowledge is used to assure the availability of new, innovative products and systems
  • Establish partnerships with our customers to develop new ideas into products
  • Actively use our worldwide distribution channels to deliver our products in the best possible terms and conditions to our customers
  • Provide in-depth product and application information to our customers
The results of the above policy are clear: Many customers rely on our products and services on a daily basis and have learned to expect a consistent high quality of our amplification products. Both internal results and co-operations with various customers resulted in a constant stream of innovative product enabling the scientific community to achieve new milestones that were previously not possible:
  • 1990: Introduction of Taq DNA Polymerase

  • 1995: Introduction of the PCR Elisa Technology the first system enabling the non-radioactive detection of PCR products in a microplate format

  • 1995: Introduction of the Expand product family the first blend of thermostable enzymes allowing the amplification of amplicons up to 10 kb

  • 1996: Introduction of the Titan product family until today the most sensitive system for detecting rare messages

  • 1997: Introduction of a ultrapure PCR Grade Nucleotides based upon a new manufacturing process developed at Roche Applied Science

  • 1998: Introduction of the C. therm product family the most robust system to amplify mRNA templates with complex secondary structures

  • 1998: Introduction of the GC RICH PCR System another blend of enzymes powering the amplification of GC RICH templates or templates with high repetitive sequences that could not be amplified with "conventional" polymerases or additives

  • 1998: Introduction of the LightCycler the first system allowing the real-time on-line monitoring of an amplification reaction

  • 1999 and 2000: Introduction of various reagents supporting the use of the LightCycler System for a wide variety of applications

  • 2000: Introduction of FastStart Taq DNA Polymerase - the next-generation PCR system for hot start applications

  • 2002: Introduction of Expand High FidelityPLUS PCR System the first product of a family of next-generation PCR Blends

Roche Applied Science continues to believe that the potential of this technology is not fully exploited yet and is strongly committed to continue serving the scientific community with new innovative systems and reagents without any compromises on its original quality philosophy.
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. SeeSNP Propietary Analysis Advantages
2. Advantages of ReadyAgarose Precast Gels Over 96-Well Handcast Gels for High-Throughput Analysis, Rev A
3. Roche Diagnostics Corporation
4. Roche Diagnostics Corporation
5. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
6. Amplified Fragment Length Polymorphism (AFLP) Analysis on Applied Biosystems Capillary Electrophoresis Systems
7. PathCheck Applied to Measurement of Protein Solutions in the SpectraMax Plus Microplate Spectrophotometer (MaxLine Application Note #26)
8. Tools for Proteomic Science II
9. Exploiting the Life Science Data Explosion to Speed New Drug Discovery
10. Automation of the Eppendorf Perfectprep BAC 96 DNA Kit on the Caliper Life Sciences Sciclone ALH 3000
11. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Advantages Roche Applied Science amplification products

(Date:8/26/2015)... ... 26, 2015 , ... Lee Biosolutions, a global biotech healthcare ... of highly valued cardiac markers used in early detection of heart disease due ... has led to the development and commercialization of important cardiac biomarkers used in ...
(Date:8/26/2015)... -- Intrexon Corporation (NYSE: XON ), a leader ... previously announced public offering of common stock, including the ... to purchase an additional 731,707 shares of common stock ...  The exercise of the underwriters, option brought the total ... to 5,609,756 shares and increased the total gross proceeds ...
(Date:8/26/2015)... After litigating and negotiating patent infringement claims brought ... United States patent RE43,651 (the ,651 patent), ... United States without any admission or concession of ... a result of the parties, settlement, the US District Court ... dismissed the case without prejudice. Under the terms ...
(Date:8/26/2015)... Boston, MA (PRWEB) , ... August 26, 2015 , ... ... venue for Boston adult stem cell technology start-up company Asymmetrex to share ... widely the capabilities of a new biomarker for counting adult tissue stem cells. , ...
Breaking Biology Technology:Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 4P2i Settles United States Litigation 2Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 2Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 3Asymmetrex Reports Positive Indicators for Crowdsourcing Campaign to Evaluate New Biomarker for Counting Adult Tissue Stem Cells for the First Time 4
... InterMune, Inc. (Nasdaq: ITMN ) today announced that ... InterMune, will present at Citi,s 4th Annual Biotech Day in ... EDT. To access a live audio webcast of the ... the investor relations page of InterMune,s corporate website at ...
... field of molecular diagnostics for lung cancer, has announced that Stephen ... Ph.D. has joined the company as Vice President of Operations and ... ... 2009 -- Allegro Diagnostics, a leader in the field of molecular ...
... Therapeutics, Inc. (Nasdaq: NLTX ), a leading company ... announced today that, in the course of reviewing the Investigational ... U.S. Food and Drug Administration (FDA) to support the initiation ... the treatment of acute heart failure, the FDA has placed ...
Cached Biology Technology:Allegro Diagnostics Expands Board and Executive Team 2Allegro Diagnostics Expands Board and Executive Team 3Allegro Diagnostics Expands Board and Executive Team 4Nile Therapeutics Provides Update on Phase II CD-NP Clinical Trial for Acute Heart Failure 2
(Date:8/18/2015)... Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ) ... Biometric Authentication & Identification Market: Focus On Modality, ... report to their offering. ... is expected to grow at an estimated CAGR ... over $25 billion (approximately) by 2020 as per ...
(Date:8/12/2015)... , Aug. 12, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced that four of its ... solution, have officially been named FIDO Certified™ by ... of the certification, Synaptics, Natural ID™ fingerprint solutions ... Authentication Framework (UAF) standard and are interoperable among ...
(Date:8/6/2015)... and TELTOW, Germany , August 6, ... Conference, SensoMotoric Instruments (SMI) shows the world,s ... , based on Epson,s Moverio BT-200 see-through head ... With this new solution, unprecedented quality and efficiency is ... with context-sensitive displays. For the first time, professionals and ...
Breaking Biology News(10 mins):Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3
... help scientists "build" new biological systems, Princeton University scientists ... enable the growth of living cells. The team ... nature, and the scientists showed that they can produce ... as proteins produced by nature,s own toolkit. ...
... ATHENS, Ohio (Jan. 6, 2011) Ohio University ... the bioengineering profession,s highest honor, the Fritz J. and ... Hood of Seattle, Washington, for his discoveries related to ... president and co-founder of the Institute for Systems Biology, ...
... at the University of Connecticut Health Center have identified a ... a predictor of heart attack. Their research, led by ... Cardiology Center, is published in the Jan. 11 issue of ... It found heart attack patients had elevated levels of the ...
Cached Biology News:Princeton scientists construct synthetic proteins that sustain life 2Princeton scientists construct synthetic proteins that sustain life 3DNA sequencing pioneer receives 2011 Russ Prize 2DNA sequencing pioneer receives 2011 Russ Prize 3